PROVIDER INITIATED TEST - The Autoimmune Analyzer Panel is a comprehensive blood test that evaluates thirteen autoimmune and inflammatory markers to help assess immune system activity and identify patterns associated with autoimmune and connective tissue disorders. This panel combines ANA screening, specific autoantibodies, complement levels, and inflammatory markers to provide a broad view of autoimmune processes.
It is commonly ordered when symptoms such as chronic fatigue, joint or muscle pain, rashes, dry eyes or mouth, unexplained inflammation, or other systemic symptoms are present. Results can help support evaluation of conditions such as lupus, Sjögren’s syndrome, scleroderma, inflammatory muscle disease, rheumatoid arthritis, and related autoimmune disorders.
The panel includes the following tests:
ANA Screen: Initial screening for antinuclear antibodies
Anti-dsDNA: Often associated with systemic lupus erythematosus (SLE)
Chromatin Antibodies: Linked to lupus and other autoimmune conditions
Ribosomal P Antibodies: Associated with lupus, including neurologic involvement
Sjogren’s Antibodies (SS-A / SS-B): Common in Sjögren’s syndrome and lupus
Smith (Sm) Antibodies: Highly specific for lupus
Sm/RNP Antibodies: Seen in mixed connective tissue disease
Centromere B Antibodies: Often linked to limited systemic sclerosis
Scleroderma Antibodies (Scl-70): Associated with systemic sclerosis
Jo-1 Antibodies: Linked to inflammatory muscle diseases
Thyroid Peroxidase (TPO) Antibodies: Associated with autoimmune thyroid disease
Complement C3 & C4: Measure immune system proteins that may be altered in autoimmune conditions
Rheumatoid Factor (RF): An antibody often elevated in rheumatoid arthritis
AutoImmune Analyzer
PROVIDER INITIATED TEST - The Autoimmune Analyzer Panel is a comprehensive blood test that evaluates thirteen autoimmune and inflammatory markers to help assess immune system activity and identify patterns associated with autoimmune and connective tissue disorders. This panel combines ANA screening, specific autoantibodies, complement levels, and inflammatory markers to provide a broad view of autoimmune processes.
It is commonly ordered when symptoms such as chronic fatigue, joint or muscle pain, rashes, dry eyes or mouth, unexplained inflammation, or other systemic symptoms are present. Results can help support evaluation of conditions such as lupus, Sjögren’s syndrome, scleroderma, inflammatory muscle disease, rheumatoid arthritis, and related autoimmune disorders.
The panel includes the following tests:
ANA Screen: Initial screening for antinuclear antibodies
Anti-dsDNA: Often associated with systemic lupus erythematosus (SLE)
Chromatin Antibodies: Linked to lupus and other autoimmune conditions
Ribosomal P Antibodies: Associated with lupus, including neurologic involvement
Sjogren’s Antibodies (SS-A / SS-B): Common in Sjögren’s syndrome and lupus
Smith (Sm) Antibodies: Highly specific for lupus
Sm/RNP Antibodies: Seen in mixed connective tissue disease
Centromere B Antibodies: Often linked to limited systemic sclerosis
Scleroderma Antibodies (Scl-70): Associated with systemic sclerosis
Jo-1 Antibodies: Linked to inflammatory muscle diseases
Thyroid Peroxidase (TPO) Antibodies: Associated with autoimmune thyroid disease
Complement C3 & C4: Measure immune system proteins that may be altered in autoimmune conditions
Rheumatoid Factor (RF): An antibody often elevated in rheumatoid arthritis
